Browse our anti-GSK3 beta (GSK3b) Antibodies

Full name:
anti-Glycogen Synthase Kinase 3 beta Antibodies (GSK3b)
On www.antibodies-online.com are 0 Glycogen Synthase Kinase 3 beta (GSK3b) Antibodies from different suppliers available. A total of 0 GSK3 beta products are currently listed.
Synonyms:
7330414F15Rik, 8430431H08Rik, C86142, fk80d11, gsk-3, GSK-3beta, GSK-3[b], gsk3, gsk3-beta, GSK3beta, wu:fb68h05, wu:fk80d11, xgsk-3
list all antibodies Gene Name GeneID UniProt
Anti-Mouse GSK3b GSK3b 56637 Q9WV60
Anti-Rat GSK3b GSK3b 84027 P18266
Anti-Human GSK3b GSK3b 2932 P49841

Show all synonyms

More Antibodies against GSK3 beta Interaction Partners

Mouse (Murine) Glycogen Synthase Kinase 3 beta (GSK3b) interaction partners

  1. changes in GSK-3beta activity and/or levels regulate the production and subsequent secretion of fractalkine (show CX3CL1 Antibodies), a chemokine (show CCL1 Antibodies) involved in the immune response that has been linked to AD and to other different neurological disorders.

  2. The activation of brain GSK-3beta expression is increased in an animal model of depressive syndrome.

  3. Findings suggest that atorvastatin attenuates diabetes-associated renal injury by reducing reactive oxygen species (ROS (show ROS1 Antibodies)) generation, RhoA (show RHOA Antibodies) activity and normalizing Akt (show AKT1 Antibodies)/GSK3beta signaling pathways.

  4. Tregs ameliorated ICH (show ACE Antibodies)-induced inflammatory injury by modulating microglia/macrophage polarization toward the M2 phenotype through the IL-10 (show IL10 Antibodies)/GSK3beta/PTEN (show PTEN Antibodies) axis

  5. GSK-3beta(+/-) mouse hearts exhibited more severe hypertrophy, which was characterized by accelerated interstitial fibrosis, than wild-type mouse hearts after transverse aortic constriction, suggesting that reduced GSK-3beta activity aggravates pressure-induced left ventricular remodeling.

  6. findings indicate a previously unknown interaction between GSK3beta and ELAV-1 (show ELAVL1 Antibodies) during acute respiratory distress syndrome , and suggest the inhibition of the ELAV-1 (show ELAVL1 Antibodies)- GSK3beta pathways as a novel acute respiratory distress syndrome treatment approach.

  7. data suggest GSK3b and mTOR (show FRAP1 Antibodies) pathways modulate this ATXN1 (show ATXN1 Antibodies) function in spinocerebellar ataxia (show USP14 Antibodies) type-1 (SCA1 (show ATXN1 Antibodies))pathogenesis that could be targeted therapeutically prior to the onset of disease symptoms in SCA1 (show ATXN1 Antibodies) and other pathologies involving dysregulation of ATXN1 (show ATXN1 Antibodies) functions.

  8. GSK3 is regulated through mechanisms independent of N-terminal serine phosphorylation in order for beta-catenin (show CTNNB1 Antibodies) to be stabilized.

  9. This study suggests that the inhibition of GSK-3beta is cardioprotective in familial dilated cardiomyopathy associated with DeltaK210 cardiac troponin T (show TNNT2 Antibodies) mutation.

  10. Data show that the fine control of excitatory transmission by glycogen synthase kinase 3 (show GSK3a Antibodies) requires recruitment of dopamine D2-receptors and depends on the presence of serotonin 5-HT1A (show HTR1A Antibodies)-receptors.

Human Glycogen Synthase Kinase 3 beta (GSK3b) interaction partners

  1. our findings identify the miR (show MLXIP Antibodies)-410/Gsk3beta/beta-catenin (show CTNNB1 Antibodies) signaling axis is a novel molecular circuit in inducing stemness of non-small cells lung cancer

  2. NOR1 (show NR4A3 Antibodies) suppresses cancer stem-like cell properties in nasopharyngeal carcinoma cells by inhibiting the AKT (show AKT1 Antibodies)-GSK-3beta-Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies)-ALDH1A1 (show ALDH1A1 Antibodies) signaling circuit.

  3. Studies show strong evidence supporting the idea that the hyperactive nutrient sensor GSK3beta plays a pivotal role in preserving quiescent hematopoietic stem cells despite its negative effects on self-renewal. [review]

  4. BMI1 (show BMI1 Antibodies) is a downstream target of GSK3 signaling.

  5. These findings suggest that the upregulation of Snail (show SNAI1 Antibodies) expression induced by H. pylori and transformation to a spindle-like shape as a consequence in gastric cancer cells are attributable to reactive oxygen species - mediated activation of Erk (show EPHB2 Antibodies) and the inactivation of GSK-3beta.

  6. changes in GSK-3beta activity and/or levels regulate the production and subsequent secretion of fractalkine (show CX3CL1 Antibodies), a chemokine (show CCL1 Antibodies) involved in the immune response that has been linked to AD and to other different neurological disorders.

  7. Data indicate that microRNA miR (show MLXIP Antibodies)-27a directly targets GSK-3beta and increases expression of beta-catenin (show CTNNB1 Antibodies) and LEF1 (show LEF1 Antibodies) in all-trans-retinoic acid (ATRA)-induced Hep2 cells.

  8. Data indicate that microRNA miR (show MLXIP Antibodies)-744 activated Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) pathway by targeting multiple negative regulators of Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling, including SFRP1 (show SFRP1 Antibodies), GSK3beta, TLE3 and NKD1 (show NKD1 Antibodies), and that NKD1 (show NKD1 Antibodies) is a major functional target of miR (show MLXIP Antibodies)-744.

  9. this study shows that cross-talk between LFA-1 (show ITGAL Antibodies) and Notch1 (show NOTCH1 Antibodies) through the Akt (show AKT1 Antibodies)/ERK (show EPHB2 Antibodies)-GSK3beta signaling enhances T cell differentiation toward Th1 (show TH1L Antibodies)

  10. SGK1 (show SGK1 Antibodies) promotes YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies) transcriptional activity. SGK1 (show SGK1 Antibodies) enhances YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies) activity by upregulating YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies). SGK1 (show SGK1 Antibodies) is a transcriptional target of YAP (show YAP1 Antibodies). SGK1 (show SGK1 Antibodies) stabilizes TAZ (show TAZ Antibodies) by inhibiting GSK3beta.

Xenopus laevis Glycogen Synthase Kinase 3 beta (GSK3b) interaction partners

  1. Novel roles for Plk (show PLK1 Antibodies) and GSK3 regulation of ADAM13 (show ADAM33 Antibodies) function in cranial neural crest cell migration.

  2. Interaction with Snail1 (show SNAI1 Antibodies)/2, and Twist function more generally, is regulated by GSK-3-beta-mediated phosphorylation of conserved sites in the WR domain.

  3. These data suggest that the interactions of beta-catenin (show CTNNB1 Antibodies) with alpha-catenin (show CTNNA1 Antibodies) and GSK-3beta exert opposing effects on the terminal projections of ventral optic axons.

Zebrafish Glycogen Synthase Kinase 3 beta (GSK3b) interaction partners

  1. Both active and inactive forms of Gsk3b mediate the cooperative signaling during angiogenesis in zebrafish embryos.

  2. a novel negative, Gsk3beta-independent control mechanism of beta-catenin and implicates Ccr7 as a long-hypothesized GPCR regulating vertebrate axis formation.

  3. The regulatory target of Wnts and Igfs, GSK3beta, is inefficiently inactivated in male fin regenerates compared with females. Pharmacological inhibition of GSK3 in males increases blastemal proliferation and restores regenerative pattern.

  4. 2-OST (show HS2ST1 Antibodies) functions within the Wnt (show WNT2 Antibodies) pathway, downstream of Wnt (show WNT2 Antibodies) ligand signaling and upstream of Gsk3beta and beta-catenin (show CTNNB1 Antibodies) intracellular localization and function

  5. Data show that GSK-3beta inhibition was sufficient to stimulate MG dedifferentiation and the formation of multipotent retinal progenitors that were capable of differentiating into all major retinal cell types.

  6. GSK3alpha, but not GSK3beta, is necessary in cardiomyocyte survival

  7. Gsk3b regulates the maintenance of neural progenitors at the midbrain-hindbrain boundary in concert with E(Spl (show SGPL1 Antibodies)) factor activity.

  8. A newly developed highly active GSK3beta inhibitor AR-534, reduced human TAU phosphorylation in TAU transgenic zebrafish.

Pig (Porcine) Glycogen Synthase Kinase 3 beta (GSK3b) interaction partners

  1. Five different isoforms of GSK3beta identified from porcine tissues, splice variants exhibit differential activity towards glycogen synthase.

  2. scratching-induced injury and repair of bronchial epithelial cells may involve inhibition of GSK3beta activity which can lead to activation of the downstream signaling through beta-catenin (show CTNNB1 Antibodies)

  3. There was no correlation of infarct size with expression or phosphorylation of p70S6K (show RPS6KB1 Antibodies) or GSK3beta in ischemic postconditioning.

Cow (Bovine) Glycogen Synthase Kinase 3 beta (GSK3b) interaction partners

  1. GSK3B and phosphorylated GSK3B regulate milk synthesis and proliferation dairy cow mammary epithelial cells.

  2. GSK3B serine phosphorylation was positively correlated with embryo development

  3. results suggest that Nav1.7-Ca2+ influx-protein kinase C-alpha pathway activated ERK1/ERK2 and p38, which increased phosphorylation of glycogen synthase kinase-3beta, decreasing tau phosphorylation

  4. IGF-I (show IGF1 Antibodies) down-regulated functional IGF-I receptor (show IGF1R Antibodies) via GSK-3beta inhibition and mTOR (show FRAP1 Antibodies) activation; constitutive activity of GSK-3beta maintained IGF-I receptor (show IGF1R Antibodies) level in nonstimulated cells.

  5. These results suggest that phospholipids and sulfatide and heparin may function as effective stimulators for autophosphorylation of GSK-3beta and for the GSK-3beta-mediated phosphorylation of SH-binding proteins, including MBP (show MBP Antibodies) and tau protein.

  6. cAMP/PKA regulation of GSK3beta/beta-catenin (show CTNNB1 Antibodies) signaling contributes to the increase in progesterone production in corpus luteum.

GSK3 beta (GSK3b) Antigen Profile

Antigen Summary

The protein encoded by this gene is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in this gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with GSK3 beta (GSK3b)

  • glycogen synthase kinase 3 beta (Gsk3b) antibody
  • glycogen synthase kinase 3 beta (GSK3B) antibody
  • glycogen synthase kinase 3 beta (gsk3b) antibody
  • 7330414F15Rik antibody
  • 8430431H08Rik antibody
  • C86142 antibody
  • fk80d11 antibody
  • gsk-3 antibody
  • GSK-3beta antibody
  • GSK-3[b] antibody
  • gsk3 antibody
  • gsk3-beta antibody
  • GSK3beta antibody
  • wu:fb68h05 antibody
  • wu:fk80d11 antibody
  • xgsk-3 antibody

Protein level used designations for GSK3b

GSK-3 beta , glycogen synthase kinase-3 beta , serine/threonine-protein kinase GSK3B , FA , factor A , GSK3beta isoform , intracellular kinase , fb68h05 , glycogen synthase kinase 3 beta variant 1 , glycogen synthase kinase 3 beta variant 2 , glycogen synthase kinase 3 beta variant 3 , glycogen synthase kinase 3 beta variant 4 , GSK-3beta

GENE ID SPECIES
56637 Mus musculus
84027 Rattus norvegicus
2932 Homo sapiens
399097 Xenopus laevis
30654 Danio rerio
478575 Canis lupus familiaris
100126852 Sus scrofa
790875 Bos taurus
418335 Gallus gallus
100348842 Oryctolagus cuniculus
Did you look for something else?